Renaissance Technologies
MIST icon

Renaissance Technologies’s Milestone Pharmaceuticals MIST Stock Holding History

Renaissance Technologies’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-129,705
Closed -$154K – 3468
2026
Q1 		$154K Buy
+129,705
New +$227K ﹤0.01% 2960
2023
Q3 		– Sell
-108,766
Closed -$310K – 3932
2023
Q2 		$310K Buy
108,766
+16,966
+18% +$64K ﹤0.01% 3111
2023
Q1 		$362K Buy
91,800
+24,600
+37% +$89.9K ﹤0.01% 3036
2022
Q4 		$266K Buy
+67,200
New +$354K ﹤0.01% 3278
2021
Q4 		– Sell
-26,400
Closed -$151K – 4106
2021
Q3 		$151K Sell
26,400
-81,154
-75% -$458K ﹤0.01% 3258
2021
Q2 		$592K Sell
107,554
-108,846
-50% -$617K ﹤0.01% 2898
2021
Q1 		$1.25M Buy
216,400
+52,400
+32% +$384K ﹤0.01% 2507
2020
Q4 		$1.1M Buy
164,000
+148,900
+986% +$997K ﹤0.01% 2457
2020
Q3 		$111K Buy
+15,100
New +$108K ﹤0.01% 3205
2020
Q2 		– Sell
-10,242
Closed -$19K – 3648
2020
Q1 		$19K Buy
+10,242
New +$177K ﹤0.01% 3375

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Renaissance Technologies's MIST Position: Q2 2026 in Review

Renaissance Technologies sold out of Milestone Pharmaceuticals (MIST) in Q2 2026, closing a stake of 129,705 shares — an estimated $154K sold.

Renaissance Technologies first reported a position in MIST in Q1 2020 and held it in 10 quarters. The position peaked at $1.25M in Q1 2021. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Renaissance Technologies reported no remaining Milestone Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 129,705 Milestone Pharmaceuticals shares in Q2 2026, an estimated $154K.
  • Renaissance Technologies first reported a position in Milestone Pharmaceuticals in Q1 2020 and held it in 10 quarters.
  • Renaissance Technologies's Milestone Pharmaceuticals position peaked at $1.25M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.